04.07.19|Golan HazaniFosun Pharma CEO Yifang Wu and Alma Lasers CEO Lior Dayan gave Calcalist their first joint interview since the Chinese conglomerate acquired the Israeli medical laser company in 2013
26.02.19|Golan HazaniFosun paid $240 million for a 95% stake in the Israeli cosmetic surgery in 2014, floating it on the Hong Kong Exchange in 2017
10.12.18|Dotan LevyThe ten-year lease is estimated at $1.7 million (NIS 6.3 million) per year. China’s Fosun Pharma bought Sisram in 2014 for $240 million, renaming it from Alma Lasers
19.09.17|Amarelle WenkertThe Fosun Pharma subsidiary debuted on the Hong Kong Stock Exchange Tuesday
10.09.17|Amarelle WenkertOn September 5, the Fosun Pharma subsidiary submitted a prospectus to the Hong Kong Stock Exchange